Academic- Drug Update: Newest Medication Approvals
29
Which drugs have been cleared for patient use in 2025? Get the latest updates on pharmacological therapies tailored to NPs in this continuing education session led by Dr. Wendy L. Wright, DNP, ANP-BC, FNP-BC, FAANP, FAAN, FNAP. Participants will learn about drug mechanisms, indications, dosages, and potential adverse effects to enhance prescribing decisions. The program includes updates on drug interactions, labeling changes, and emerging treatment protocols. Covered medications include: Lecanemab-irmb, Donanemab-azbt, Aprocitentan, Sotagliflozin, Tirzepatide, Ensifentrine, Vonoprazan, and Epinephrine Nasal Spray.